These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 38528826)

  • 1. Cervical cancer in Thailand: 2023 update.
    Wongpratate M; Bumrungthai S
    Obstet Gynecol Sci; 2024 May; 67(3):261-269. PubMed ID: 38528826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study.
    Simms KT; Steinberg J; Caruana M; Smith MA; Lew JB; Soerjomataram I; Castle PE; Bray F; Canfell K
    Lancet Oncol; 2019 Mar; 20(3):394-407. PubMed ID: 30795950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study.
    Castanon A; Landy R; Pesola F; Windridge P; Sasieni P
    Lancet Public Health; 2018 Jan; 3(1):e34-e43. PubMed ID: 29307386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.
    Praditsitthikorn N; Teerawattananon Y; Tantivess S; Limwattananon S; Riewpaiboon A; Chichareon S; Ieumwananonthachai N; Tangcharoensathien V
    Pharmacoeconomics; 2011 Sep; 29(9):781-806. PubMed ID: 21838332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
    Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
    Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Canfell K; Kim JJ; Brisson M; Keane A; Simms KT; Caruana M; Burger EA; Martin D; Nguyen DTN; Bénard É; Sy S; Regan C; Drolet M; Gingras G; Laprise JF; Torode J; Smith MA; Fidarova E; Trapani D; Bray F; Ilbawi A; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):591-603. PubMed ID: 32007142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types.
    Armstrong EP
    J Manag Care Pharm; 2010 Apr; 16(3):217-30. PubMed ID: 20331326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cervical cancer in Ethiopia: a review of the literature.
    Derbie A; Mekonnen D; Nibret E; Misgan E; Maier M; Woldeamanuel Y; Abebe T
    Cancer Causes Control; 2023 Jan; 34(1):1-11. PubMed ID: 36242682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences in the prevention and screening of cervical cancer within Thailand.
    Kengsakul M; Laowahutanont P; Wilailak S
    Int J Gynaecol Obstet; 2021 Jan; 152(1):48-52. PubMed ID: 33181003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scaling up cervical cancer screening in the midst of human papillomavirus vaccination advocacy in Thailand.
    Yothasamut J; Putchong C; Sirisamutr T; Teerawattananon Y; Tantivess S
    BMC Health Serv Res; 2010 Jul; 10 Suppl 1(Suppl 1):S5. PubMed ID: 20594371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of human papillomavirus vaccination and cervical cancer screening in Thailand.
    Sharma M; Ortendahl J; van der Ham E; Sy S; Kim JJ
    BJOG; 2012 Jan; 119(2):166-76. PubMed ID: 21481160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.
    Brinkman JA; Caffrey AS; Muderspach LI; Roman LD; Kast WM
    Eur J Gynaecol Oncol; 2005; 26(2):129-42. PubMed ID: 15857016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the effect of HIV on cervical cancer elimination in South Africa: Comparative modelling of the impact of vaccination and screening.
    Boily MC; Barnabas RV; Rönn MM; Bayer CJ; van Schalkwyk C; Soni N; Rao DW; Staadegaard L; Liu G; Silhol R; Brisson M; Johnson LF; Bloem P; Gottlieb S; Broutet N; Dalal S
    EClinicalMedicine; 2022 Dec; 54():101754. PubMed ID: 36583170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries.
    Brisson M; Kim JJ; Canfell K; Drolet M; Gingras G; Burger EA; Martin D; Simms KT; Bénard É; Boily MC; Sy S; Regan C; Keane A; Caruana M; Nguyen DTN; Smith MA; Laprise JF; Jit M; Alary M; Bray F; Fidarova E; Elsheikh F; Bloem PJN; Broutet N; Hutubessy R
    Lancet; 2020 Feb; 395(10224):575-590. PubMed ID: 32007141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus (HPV) vaccination for the prevention of HPV 16/18 induced cervical cancer and its precursors.
    Damm O; Nocon M; Roll S; Vauth C; Willich S; Greiner W
    GMS Health Technol Assess; 2009 Mar; 5():Doc04. PubMed ID: 21289891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico.
    Reynales-Shigematsu LM; Rodrigues ER; Lazcano-Ponce E
    Arch Med Res; 2009 Aug; 40(6):503-13. PubMed ID: 19853192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of HPV vaccination and cervical cancer screening in England by ethnicity: a modelling study.
    Johnson HC; Lafferty EI; Eggo RM; Louie K; Soldan K; Waller J; Edmunds WJ
    Lancet Public Health; 2018 Jan; 3(1):e44-e51. PubMed ID: 29307388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-utility and budget impact analyses of cervical cancer screening using self-collected samples for HPV DNA testing in Thailand.
    Kositamongkol C; Kanchanasurakit S; Mepramoon E; Talungchit P; Chaopotong P; Kengkla K; Chaisathaphol T; Saokaew S; Phisalprapa P
    BMC Public Health; 2023 Dec; 23(1):2413. PubMed ID: 38049773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knowledge regarding human papillomavirus and cervical cancer prevention among medical students from Chulalongkorn University in Thailand.
    Sukrong M; Prapaisilp P; Juntamongkol T; Siranart N; Phoolcharoen N; Assavapokee N; Sirisabya N; Santibenchakul S
    BMC Womens Health; 2024 Feb; 24(1):129. PubMed ID: 38373946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.